Gabelli Funds’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-771,489
| Closed | -$30.4M | – | 1196 |
|
|
2023
Q2 | $30.4M | Buy |
+771,489
| New | +$27.2M | 0.23% | 116 |
|
|
2019
Q3 | – | Sell |
-20,000
| Closed | -$26K | – | 1148 |
|
|
2019
Q2 | $26K | Buy |
20,000
+6,000
| +43% | +$8.23K | ﹤0.01% | 1146 |
|
|
2019
Q1 | $20K | Sell |
14,000
-4,000
| -22% | -$5.59K | ﹤0.01% | 1132 |
|
|
2018
Q4 | $22K | Sell |
18,000
-2,000
| -10% | -$3.88K | ﹤0.01% | 1137 |
|
|
2018
Q3 | $47K | Hold |
20,000
| – | – | ﹤0.01% | 1141 |
|
|
2018
Q2 | $55K | Buy |
20,000
+2,000
| +11% | +$5.52K | ﹤0.01% | 1139 |
|
|
2018
Q1 | $49K | Hold |
18,000
| – | – | ﹤0.01% | 1138 |
|
|
2017
Q4 | $56K | Sell |
18,000
-1,000
| -5% | -$2.81K | ﹤0.01% | 1108 |
|
|
2017
Q3 | $54K | Hold |
19,000
| – | – | ﹤0.01% | 1113 |
|
|
2017
Q2 | $49K | Hold |
19,000
| – | – | ﹤0.01% | 1125 |
|
|
2017
Q1 | $70K | Sell |
19,000
-19,000
| -50% | -$80.3K | ﹤0.01% | 1126 |
|
|
2016
Q4 | $184K | Buy |
38,000
+19,000
| +100% | +$564K | ﹤0.01% | 1104 |
|
|
2016
Q3 | $876K | Hold |
19,000
| – | – | 0.01% | 939 |
|
|
2016
Q2 | $970K | Hold |
19,000
| – | – | 0.01% | 934 |
|
|
2016
Q1 | $803K | Hold |
19,000
| – | – | ﹤0.01% | 934 |
|
|
2015
Q4 | $1.49M | Hold |
19,000
| – | – | 0.01% | 828 |
|
|
2015
Q3 | $770K | Sell |
19,000
-1,000
| -5% | -$53K | ﹤0.01% | 890 |
|
|
2015
Q2 | $1.04M | Hold |
20,000
| – | – | 0.01% | 873 |
|
|
2015
Q1 | $931K | Hold |
20,000
| – | – | ﹤0.01% | 883 |
|
|
2014
Q4 | $897K | Hold |
20,000
| – | – | ﹤0.01% | 896 |
|
|
2014
Q3 | $779K | Buy |
+20,000
| New | +$785K | ﹤0.01% | 930 |
|
Gabelli Funds's ISEE Position: Q3 2023 in Review
Gabelli Funds sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 771,489 shares — an estimated $30.4M sold.
Gabelli Funds first reported a position in ISEE in Q3 2014 and held it in 21 quarters. The position peaked at $30.4M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- Gabelli Funds reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Gabelli Funds sold 771,489 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $30.4M.
- Gabelli Funds first reported a position in IVERIC bio, Inc. Common Stock in Q3 2014 and held it in 21 quarters.
- Gabelli Funds's IVERIC bio, Inc. Common Stock position peaked at $30.4M in Q2 2023.
- 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.
Based on Gabelli Funds's 13F filing for Q3 2023, filed 8 Nov 2023.